The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksArbuthnot Regulatory News (ARBB)

Share Price Information for Arbuthnot (ARBB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,060.00
Bid: 1,020.00
Ask: 1,100.00
Change: -5.00 (-0.47%)
Spread: 80.00 (7.843%)
Open: 1,065.00
High: 0.00
Low: 0.00
Prev. Close: 1,065.00
ARBB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Hardman & Co Research: Arbuthnot Banking Group (ARBB): 2018 results: growth and diversity

30 Apr 2019 07:15

Hardman & Co Research Hardman & Co Research: Arbuthnot Banking Group (ARBB): 2018 results: growth and diversity 30-Apr-2019 / 07:15 GMT/BST


Hardman & Co Research: 2018 results: growth and diversity

The 28 March results showed the great progress made in profitably deploying the capital ABG generated from the partial sale of its stake in Secure Trust Bank (STB). Underlying EPS rose from 17.6p in 2017 to 40.3p, loans grew 17% to £1,225m, and deposits increased 23% to £1,714m. New businesses are diversifying income and credit risk. Commercial Banking reported a £2.5m profit (2017: £2.1m loss), Asset-Based Lending facilities totalled £43m at end-December, Specialist Finance got its first loan sanctioned in 2019, and Arbuthnot Direct is live. The group is well funded (loans 71% of deposits) and capital ratios are strong (Core Tier 1: 15.9%).Please click here for the full report:

https://www.hardmanandco.com/?post_type=research&p=2762&preview=true

To contact us: Hardman & Co 35 New Broad Street London EC2M 1NH www.hardmanandco.comFollow us on Twitter @HardmanandCo Contact: Mark Thomas +44 20 7194 7622 mt@hardmanandco.com

Hardman & Co Research can still be accessed for free after MiFID II. Please click here to read the statement.

About Hardman & Co: For the past 21 years Hardman has been producing specialist research designed to improve investors' understanding of companies, sectors, industries and investment securities. Our analysts are highly experienced in their sectors, and have often been highly rated by professional investors for their knowledge. Our focus is to raise companies' profiles across the UK and abroad with outstanding research, investor engagement programmes and advisory services. Some of our notes have been commissioned by the company which is the subject of the note; this is clearly stated in the disclaimer where this is the case.

Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843. Hardman Research Ltd is registered at Companies House with number 8256259.

Our research is provided for the use of the professional investment community, market counterparties and sophisticated and high net worth investors as defined in the rules of the regulatory bodies. It is not intended to be made available to unsophisticated retail investors. Anyone who is unsure of their categorisation should consult their professional advisors. This research is neither an offer, nor a solicitation, to buy or sell any security. Please read the note for the full disclaimer.


Dissemination of a CORPORATE NEWS, transmitted by EQS Group.The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

804967 30-Apr-2019 

corporate announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
21st Oct 20107:00 amRNSUpdate on third quarter trading
23rd Sep 201011:08 amRNSDirector/PDMR Shareholding
13th Sep 201011:30 amRNSDirectorate Change
4th Aug 20107:00 amRNSHalf Yearly Report
19th Jul 20103:29 pmRNSNotice of Results
12th May 20104:23 pmRNSAGM Statement
10th May 20105:56 pmRNSDirectorate Change
11th Mar 20105:17 pmRNSStatement re Director
11th Mar 20107:00 amRNSFinal Results
25th Feb 201011:09 amRNSNotice of Results
2nd Feb 20104:04 pmRNSTotal Voting Rights
7th Jan 20104:13 pmRNSTransaction in Own Shares
7th Jan 20107:00 amRNSTrading Statement
22nd Dec 20093:29 pmRNSDirector/PDMR Shareholding
3rd Nov 200910:00 amRNSDirectorate Change
22nd Oct 20097:00 amRNSUpdate on Third Quarter Trading
15th Sep 200912:55 pmRNSDirector/PDMR Shareholding
10th Sep 20092:21 pmRNSDirector/PDMR Shareholding
9th Sep 20092:51 pmRNSDirector/PDMR Shareholding
3rd Sep 200912:54 pmRNSDirector/PDMR Shareholding
3rd Sep 200912:48 pmRNSDirector/PDMR Shareholding
21st Aug 20094:51 pmRNSPurchase of consumer assets
29th Jul 20097:00 amRNSHalf Yearly Report
30th Jun 20094:57 pmRNSTransaction in Own Shares & Total Voting Rights
25th Jun 20095:14 pmRNSTransaction in Own Shares
22nd Jun 200910:15 amRNSStructured Product Distribution Business Launched
2nd Jun 200910:27 amRNSLaunch of Real Estate Fund Management Business
13th May 20094:25 pmRNSAGM Statement
7th Apr 20094:37 pmRNSTotal Voting Rights
2nd Apr 20094:52 pmRNSTransaction in Own Shares
26th Mar 20095:03 pmRNSTransaction in Own Shares
25th Mar 20095:20 pmRNSTransaction in Own Shares
19th Mar 20095:43 pmRNSTransaction in Own Shares
18th Mar 20095:05 pmRNSTransaction in Own Shares
12th Mar 20094:54 pmRNSTransaction in Own Shares
12th Mar 20097:00 amRNSFinal Results 2008
26th Feb 200910:01 amRNSPurchase of Consumer Assets
16th Jan 20098:57 amRNSHolding(s) in Company
8th Jan 20094:59 pmRNSTransaction in Own Shares
19th Dec 20087:00 amRNSTrading Statement
17th Dec 20089:17 amRNSChange of Adviser
27th Nov 20084:57 pmRNSTransaction in Own Shares
24th Nov 20084:50 pmRNSTransaction in Own Shares
19th Nov 20084:50 pmRNSTransaction in Own Shares
14th Nov 20084:58 pmRNSTransaction in Own Shares
13th Nov 20084:55 pmRNSTransaction in Own Shares
10th Nov 20084:14 pmRNSDirector/PDMR Shareholding
5th Nov 20084:46 pmRNSTransaction in Own Shares
4th Nov 20084:54 pmRNSTransaction in Own Shares
27th Oct 20084:57 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.